Literature DB >> 3102599

Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice.

A P Dang-Vu, D S Pisetsky, J B Weinberg.   

Abstract

To assess the role of macrophages (MAC) in the pathogenesis of systemic lupus erythematosus, we investigated functional aspects of peritoneal MAC obtained from autoimmune MRL/MpJ-lpr/lpr (MRL-lpr) mice. MRL-lpr and control C3H/HeN MAC were obtained from untreated mice or mice injected i.p. with 1 ml of 10% sterile peptone 3 days before cell harvest. MRL-lpr mice had significantly more peritoneal cells (MAC and lymphocytes) than did control mice. In endotoxin-free conditions, MRL-lpr MAC were similar to C3H/HeN MAC in their baseline, and IFN-gamma and/or LPS enhanced cytolysis of 3T12 fibrosarcoma tumor cells. Compared with C3H/HeN MAC, MRL-lpr MAC had a significant increase in antibody-dependent cellular cytotoxicity activity against sheep erythrocytes. This enhanced activity was not accompanied by a similar increase in adherence and/or phagocytosis of the same targets. Finally, in response to phorbol myristate acetate stimulation, both resident and peptone-induced MAC from MRL-lpr mice produced significantly more hydrogen peroxide than did those from control mice. These results indicate that MAC from MRL-lpr mice display features of selective "activation", and suggest that MAC or their products may play a role in the pathogenesis of inflammatory disorders seen in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102599

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Chronic administration of dexamethasone results in Fc receptor up-regulation and inhibition of class I antigen expression on macrophages from MRL/lpr autoimmune mice.

Authors:  S H Zuckerman; G F Evans; N Bryan
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 2.  Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.

Authors:  Christopher M Reilly; Gary S Gilkeson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  An acquired defect in IgG-dependent phagocytosis explains the impairment in antibody-mediated cellular depletion in Lupus.

Authors:  Anupama Ahuja; Lino L Teichmann; Haowei Wang; Robert Dunn; Marilyn R Kehry; Mark J Shlomchik
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

4.  Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.

Authors:  D Ashany; X Song; E Lacy; J Nikolic-Zugic; S M Friedman; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism.

Authors:  H Kanno; M Nose; J Itoh; Y Taniguchi; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

7.  Role of interferon-gamma on the in vivo expression of functional interleukin-2 receptors by murine macrophages.

Authors:  B Dugas; L Friteau; H Schellekens; D Lando; C Damais
Journal:  Inflammation       Date:  1991-06       Impact factor: 4.092

8.  Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZBxNZW F1 mice.

Authors:  J T Venkatraman; B Chandrasekar; J D Kim; G Fernandes
Journal:  Lipids       Date:  1994-08       Impact factor: 1.880

9.  Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice.

Authors:  M A Yui; W H Brissette; D C Brennan; R P Wuthrich; V E Rubin-Kelley
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

10.  Immune complex-degradation ability of macrophages in MRL/Mp-lpr/lpr lupus mice and its regulation by cytokines.

Authors:  H Kanno; O Tachiwaki; M Nose; M Kyogoku
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.